Table 3.
Patient treatment details (n = 16)
| Variable - 1st line | n (%), median (range) |
|---|---|
|
Initial management at diagnosis of ULMS |
|
| Surgical resection alone |
3 (19%) |
| Surgical resection and BSO |
13 (81%) |
|
Number of prior chemotherapy regimens |
|
| 0 |
12 (75%) |
| 1 |
2 (12.5%) |
| 2 |
2 (12.5%) |
|
Prior exogenous estrogens |
|
| Tamoxifen |
3 (19%) , 60 months |
| HRT |
4 (25%), 48 months (24–96) |
|
Prior pelvic radiotherapy |
1 (6%) |
| Median interval between diagnosis (surgery) and letrozole initiation | 37 months (2–308) |
ULMS, uterine leiomyosarcoma; BSO, bilateral salpingo-oophorectomy; HRT, hormonal replacement therapy.